VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer

BACKGROUND: VEGF/VEGFR2 pathway is the central therapeutic target in anti-angiogenic treatment in multiple cancers. However, little work has been carried out concerning the pro-malignancy functions of VEGFR2 that are independent of its pro-angiogenesis effects in gastric cancer. Here, we demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Lian, Li, Xiang-Li, Xu, Meng-Dan, Li, Xian-Min, Wu, Meng-Yao, Zhang, Yan, Tao, Min, Li, Wei, Shen, Xiao-Ming, Zhou, Chong, Jiang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393973/
https://www.ncbi.nlm.nih.gov/pubmed/30819137
http://dx.doi.org/10.1186/s12885-019-5322-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393973/
https://www.ncbi.nlm.nih.gov/pubmed/30819137
http://dx.doi.org/10.1186/s12885-019-5322-0

Ejemplares similares